Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Medicinal Chemistry|February 21, 1992
Novel anticancer prodrugs of butyric acid. 2A Nudelman, M Ruse, A Aviram, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1997
Effect of the cytostatic butyric acid pro-drug, pivaloyloxymethyl butyrate, on the tumorigenicity of cancer cellsA Aviram, A Rephaeli, M Shaklai, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 19, 2012
A multifunctional 5-aminolevulinic acid derivative induces erythroid differentiation of K562 human erythroleukemic cellsG Berkovitch-Luria, S Yakobovitch, M Weitman, et al.International Journal of Oncology|May 14, 2011
Butyrate-induced differentiation in leukemic myeloid cells - in-vitro and in-vivo studiesA Rephaeli, J Nordenberg, A Aviram, et al.British Journal of Cancer|May 3, 2007
Anticancer prodrugs of butyric acid and formaldehyde protect against doxorubicin-induced cardiotoxicityA Rephaeli, S Waks-Yona, A Nudelman, et al.Investigational New Drugs|December 16, 1998
Activity of pivaloyloxymethyl butyrate, a novel anticancer agent, on primary human tumor colony-forming unitsL L Siu, D D Von Hoff, A Rephaeli, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 12, 2012
A histone deacetylase inhibitory prodrug - butyroyloxymethyl diethyl phosphate - protects the heart and cardiomyocytes against ischemia injuryG Kessler-Icekson, E Hochhauser, T Sinai, et al.European Journal of Medicinal Chemistry|March 7, 2001
Prodrugs of butyric acid. Novel derivatives possessing increased aqueous solubility and potential for treating cancer and blood diseasesA Nudelman, E Gnizi, Y Katz, et al.Pageof 3